Skip to main content
Clinical Trials

A Phase 1/2 Trial of Selinexor (KPT-330) and Radiation Therapy in Newly-Diagnosed Pediatric Diffuse Intrinsic Pontine Glioma (DIPG) and High-Grade Glioma (HGG) (CTMS# 22-0089)

ClinicalTrials.gov Identifier

ClinicalTrials.gov registration not required

Principal Investigator

Anne–Marie Langevin MD

For more information about this study
View Details

About This Study